InspireMD, Inc. (NSPR) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
InspireMD, Inc.
Sector
Healthcare
Industry
Medical - Devices
Employees
85
First IPO Date
April 12, 2011
Key Executives
| Name | Title | Pay | Year Born |
| Marvin L. Slosman | President, Chief Executive Officer & Director | 1.01M | 1964 |
| Sol J. Barer | Special Advisor to the Board | 13,917 | 1947 |
| Michael A. Lawless | CFO, Secretary & Treasurer | 470,081 | 1969 |
| Shane Thomas Gleason | Chief Commercial Officer | 579,467 | 1975 |
| Pete Ligotti | Executive Vice President & GM of North America | 0 | N/A |
| Donna DeChant | Vice President of Human Resources & Organizational Development | 0 | N/A |
| Amir Kohen | Executive Vice President of Finance & Regional Manager | 0 | N/A |
| Peter A. Soukas | Chief Medical Officer | 0 | N/A |
Description
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
